Hyperfine Says Question Is When, Not If, Portable MRI Will Impact The World; CEO Dave Scott Discusses

 
• By Marion Webb

Hyperfine, which markets the first US FDA-cleared portable MRI system, is facing COVID-related headwinds in bringing its system to hospitals, but CEO Dave Scott says wider adoption of the disruptive solution is inevitable. The company is going public today after combining with the HealthCor Catalio Acquisition Corp.

Patient's head being scanned by Hyperfine's portable magnetic resonance imaging system, controlled by tech using an iPad
• Source: Hyperfine

More from AI

More from Digital Technologies